Evaluation of the clinimetric properties of the Early Inflammatory Arthritis-self-administered comorbidity questionnaire

Rheumatology

Volumn 48, Issue 4, 2009, Pages 390-394

  Baron, Murray ^a,b   Schieir, Orit ^a,b   Hudson, Marie ^a,b   Steele, Russell ^b   Janelle Montcalm, Audrëe ^a   Bernstein, Jessica ^a   Starr, Michael ^b   Gagné, Michel ^b   Stein, Michael ^b   Kang, Harb ^b   Kapusta, Morton ^b   Couture, François ^b   Fitzcharles, Mary Ann ^b   Garfield, Bruce ^b   Ménard, Henri A ^b   Berkson, Laeora ^a   Pineau, Christian ^b   Gutkowski, Andrzej ^b   Zummer, Michel ^c   Mathieu, Jean Pierre ^c   Mercille, Suzanne ^c   Ligier, Sophie ^c   Krasny, Jiri ^b   Bertrand, Carole ^c   Yuen, Sai Yan ^c   Schulz, Jan ^b   more..

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Arthritis; Comorbidity; Early inflammation; Psychometrics; Questionnaires; RA

Indexed keywords

ADULT; ANEMIA; ARTHRITIS; ARTICLE; BACKACHE; CLINICAL ASSESSMENT; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE ACTIVITY; EARLY INFLAMMATORY ARTHRITIS; FEMALE; FUNCTIONAL ASSESSMENT; HEART DISEASE; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; NEOPLASM; OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RELIABILITY; SCORING SYSTEM; ULCER; VALIDITY;

ADULT; AGED; ARTHRITIS; COMORBIDITY; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY;

EID: 63249104468     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken504     Document Type: Article

References (45)

1. Blashfield RK. Comorbidity and classification. In: Maser D, Cloninger C, eds. Comorbidity of mood and anxiety disorders. Washington DC: American Psychiatric Association Press, 1990:61-82.
2. Gabriel SE, Crowson CS, O'Fallon WM. A comparison of two comorbidity instruments in arthritis. J Clin Epidemiol 1999;52:1137-42.
3. Dodds TA, Martin DP, Stolov WC, Deyo RA. A validation of the functional independence measurement and its performance among rehabilitation inpatients. Arch Phys Med Rehabil 1993;74:531-6.
4. Cleary PD, Greenfield S, Mulley AG et al. Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. J Am Med Assoc 1991;266:73-9.
5. Greenfield S, Aronow HU, Elashoff RM, Watanabe D. Flaws in mortality data. The hazards of ignoring comorbid disease. J Am Med Assoc 1988;260:2253-5.
6. Katz JN, Wright EA, Guadagnoli E, Liang MH, Karlson EW, Cleary PD. Differences between men and women undergoing major orthopedic surgery for degenerative arthritis. Arthritis Rheum 1994;37:687-94.
7. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-cm administrative databases. J Clin Epidemiol 1992;45:613-9.
8. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003;56:221-9.
9. Albertsen P, Fryback D, Storer B, Kolon T, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. J Am Med Assoc 1995;274: 626-31.
10. Greenfield S, Blanco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. J Am Med Assoc 1987;257:2766-70.
11. Stucki G, Liang MH, Lipson SJ, Fossel AH, Katz JN. Contribution of neuromuscular impairment to physical functional status in patients with lumbar spinal stenosis. J Rheumatol 1994;21:1338-43.
12. Caruso I, Santandrea S, Sarzi Puttini P et al. Clinical, laboratory and radiographic features in early rheumatoid arthritis. J Rheumatol 1990;17:1263-7.
13. Berkanovic E, Hurwicz ML. Rheumatoid arthritis and comorbidity. J Rheumatol 1990;17:888-92.
14. Talamo J, Frater A, Gallivan S, Young A. Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis. Br J Rheumatol 1997;36:463-9.
15. Leardini G, Salaffi F, Montanelli R, Gerzeli S, Canesi B. A multicenter cost-of-illness study on rheumatoid arthritis in Italy. Clin Exp Rheumatol 2002;20:505-15.
16. Gabriel SE, Crowson CS, O'Fallon WM. Comorbidity in arthritis. J Rheumatol 1999; 26:2475-9.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-83.
18. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 1993;31:141-54.
19. Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schiff SF. Problems of comorbidity in mortality after prostatectomy. J Am Med Assoc 1992;267:1077-82.
20. Rubin HR, Wu AW. The risk of adjustment. Med Care 1992;30:973-5.
21. Linet MS, Harlow SD, McLaughlin JK, McCaffrey LD. A comparison of interview data and medical records for previous medical conditions and surgery. J Clin Epidemiol 1989;42:1207-13.
22. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84.
23. Colditz GA, Martin P, Stampfer MJ et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894-900.
24. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996;49:1407-17.
25. Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I. Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol 1997;145:762-9.
26. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003;49:156-63.
27. Stier D, Greenfield S, Lubeck D et al. Quantifying comorbidity in a disease-specific cohort: Adaptation of the total illness burden index to prostate cancer. Urology 1999; 54:424-9.
28. Hayward R, Manning W, Kaplan S, Wagner E, Greenfield S. Starting insulin therapy in patients with type 2 diabetes: Effectiveness, complications, and resource utilization. J Am Med Assoc 1997;278:1663-69.
29. Cooperating clinics of the American Rheumatism Association. A seven-day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum 1965;8: 302-335.
30. Felson DT, Anderson JJ, Boers M et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
31. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
32. Wolfe F. Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 rheumatoid arthritis patients following leflunomide initiation. J Rheumatol 2001;28:982-9.
33. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: A review of its history, issues, progress, and documentation. J Rheumatol 2003;30:167-78.
34. Melzack R. The Short-form McGill Pain Questionnaire. Pain 1987;30:191-7.
35. Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975;1:277-99.
36. Ware JJ, Snow K, Kosinski M, Gandek B. SF-36 health survey: Manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993.
37. World Health Organization Disease Assessment Schedule. http://www.who.int/icidh/whodas/index.html. (7 January 2009, date last accessed)
38. Clarke AE, Zowall H, Levinton C et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: A 12 year study. J Rheumatol 1997;24: 1051-60.
39. Clarke AE, Petri MA, Manzi S et al. An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-nation study group. J Rheumatol 1999;26:1500-11.
40. Bonnett DG. Statistics in medicine. Stat Med 2002;21:1331-5.
41. Demers L, Monette M, Descent M, Jutai J, Wolfson C. The psychosocial impact of assistive devices scale (PIADS): Translation and preliminary psychometric evaluation of a Canadian-French version. Qual Life Res 2002;11:583-92.
42. Streiner D, Norman G. Health measurement scales: A practical guide to their development and use. New York: Oxford University Press, 2003:192.
43. Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. Boston, MA: McGraw-Hill, 1988.
44. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000;29:891-8.
45. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51.